Study reveals how chronic blood cancer transitions to aggressive disease

by Julia Evangelou Strait,Washington University School of MedicineA study from Washington University School of Medicine in St. Louis suggests a strategy for preventing a chronic, slow-growing ty

Updated on: February 23,2024

Study reveals how chronic blood cancer transitions to aggressive disease

by Julia Evangelou Strait,Washington University School of MedicineA study from Washington University School of Medicine in St. Louis suggests a strategy for preventing a chronic, slow-growing ty

Updated on:February 23,2024

Better cancer treatment inspired by the foam on your latte

by Jennifer Brown,University of IowaSchematic diagram illustrating how O2-GeMs are fabricated and incorporated into clinically relevant therapies for treatment-refractory tumors, such as MPNSTs.

Updated on: January 02,2024

Better cancer treatment inspired by the foam on your latte

by Jennifer Brown,University of IowaSchematic diagram illustrating how O2-GeMs are fabricated and incorporated into clinically relevant therapies for treatment-refractory tumors, such as MPNSTs.

Updated on:January 02,2024

Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma

by Dana-Farber Cancer InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 maj

Updated on: May 27,2024

Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma

by Dana-Farber Cancer InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 maj

Updated on:May 27,2024

New therapy harnesses patients' blood cells to fight tumors

by Win Reynolds,Northwestern UniversityCredit: CC0 Public DomainAdoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesse

Updated on: January 15,2024

New therapy harnesses patients' blood cells to fight tumors

by Win Reynolds,Northwestern UniversityCredit: CC0 Public DomainAdoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesse

Updated on:January 15,2024

'Bet hedging' explains the efficacy of many combination cancer therapies

by Harvard Medical SchoolKiller T cells surround a cancer cell. Credit: NIHThe efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rat

Updated on: March 14,2024

'Bet hedging' explains the efficacy of many combination cancer therapies

by Harvard Medical SchoolKiller T cells surround a cancer cell. Credit: NIHThe efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rat

Updated on:March 14,2024

Researchers identify women with twice the risk of cancer in both breasts

by Mayo ClinicCumulative incidence of CBC risk in PV carriers. Cumulative incidence plots for first contralateral breast cancers after primary breast cancer. Cumulative incidence is plotted again

Updated on: February 18,2024

Researchers identify women with twice the risk of cancer in both breasts

by Mayo ClinicCumulative incidence of CBC risk in PV carriers. Cumulative incidence plots for first contralateral breast cancers after primary breast cancer. Cumulative incidence is plotted again

Updated on:February 18,2024

Researchers uncover racial and ethnic disparities in a widely used precision oncology data registry

by Katie Marquedant,Massachusetts General HospitalSample size estimation to detect differences in mutational proportions between white and racial/ethnic minority patients at varying power increm

Updated on: February 18,2024

Researchers uncover racial and ethnic disparities in a widely used precision oncology data registry

by Katie Marquedant,Massachusetts General HospitalSample size estimation to detect differences in mutational proportions between white and racial/ethnic minority patients at varying power increm

Updated on:February 18,2024

Study reveals extent of residual lung damage after COVID-19 hospitalization

by American Thoracic SocietyNew study finds up to 11 percent of patients had lung scarring after COVID-19 infection that may get worse over time. Credit: ATSIn a new study published online in the

Updated on: February 01,2024

Study reveals extent of residual lung damage after COVID-19 hospitalization

by American Thoracic SocietyNew study finds up to 11 percent of patients had lung scarring after COVID-19 infection that may get worse over time. Credit: ATSIn a new study published online in the

Updated on:February 01,2024

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur

Updated on: November 09,2024

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur

Updated on:November 09,2024

Study finds education and navigation increase cancer genetic counseling and/or testing

by Rutgers Cancer Institute of New JerseyGraphical depiction of TP and TCN interventions. (a) Baseline survey, which captured sociodemographic information (age, rural status, etc), self-reported healt

Updated on: January 23,2024

Study finds education and navigation increase cancer genetic counseling and/or testing

by Rutgers Cancer Institute of New JerseyGraphical depiction of TP and TCN interventions. (a) Baseline survey, which captured sociodemographic information (age, rural status, etc), self-reported healt

Updated on:January 23,2024

AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recur

Updated on: April 28,2024

AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recur

Updated on:April 28,2024

A step towards precision oncology for patients with metastatic urothelial carcinoma

byUniversity of BonnCredit: Pixabay/CC0 Public DomainDr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University

Updated on: January 21,2024

A step towards precision oncology for patients with metastatic urothelial carcinoma

byUniversity of BonnCredit: Pixabay/CC0 Public DomainDr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University

Updated on:January 21,2024